No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

GE HealthCare Announces Availability of Next-Generation bkActiv for Guiding Urology, Colorectal and Pelvic Floor Surgeries

Editor: What To Know

  • With the acquisition of BK Medical in 2021, GE HealthCare adds the fast-growing field of real-time surgical visualization to its pre- and post-operative ultrasound capabilities, creating an end-to-end offering through the full continuum of care.
  • With this addition, the bkActiv now supports next level image quality of the prostate, kidney, and bladder, and has sensitive color doppler to visualize and measure the speed and direction of blood flow during the most complex surgical procedures.
  • “By expanding the bkActiv system, we are giving physicians the tools they need to provide precise treatment with the ability to see fine details in image guidance, which ultimately may allow for better outcomes for people who require urology, colorectal and pelvic floor procedures,” said Urvi Vyas, General Manager, Surgical Visualization &.

GE HealthCare (Nasdaq: GEHC) announced today the next-generation bkActiv is now available for guiding urology, colorectal and pelvic floor surgical procedures. The flagship intraoperative ultrasound imaging system, developed by BK Medical – a subsidiary of GE HealthCare, was designed to deliver high-performance ultrasound guidance with a simplified, intuitive user experience for surgeons. The bkActiv’s automatic no-touch autogain and advanced algorithms provide unmatched image quality, enabling confident decision making during surgical procedures. The system allows for minimal user interaction so that surgeons can focus on their patients.

“By expanding the bkActiv system, we are giving physicians the tools they need to provide precise treatment with the ability to see fine details in image guidance, which ultimately may allow for better outcomes for people who require urology, colorectal and pelvic floor procedures,” said Urvi Vyas, General Manager, Surgical Visualization & Guidance, Ultrasound at GE HealthCare, “We are proud to be the trusted partner for surgeons around the world given our long history of leadership in imaging and innovation.”

The bkActiv is a high-performance imaging system that allows for detailed, real-time surgical visualization, refined through decades of research, real-world use, and extensive user feedback. With this addition, the bkActiv now supports next level image quality of the prostate, kidney, and bladder, and has sensitive color doppler to visualize and measure the speed and direction of blood flow during the most complex surgical procedures. Combined with the new advanced portfolio of specialized, sterilizable transducers, needle guides, and procedure packs, the solution is designed to assist surgeons from simple procedures, such as biopsies, to the most advanced robotic surgeries.

The system’s features are designed with the physician in mind, and include:

  • Intuitive design with True-Sense touch technology and Smart Button that allow surgeons to operate the system with one hand for full control during the procedure
  • Advanced transducer portfolio including robotic and laparoscopic transducers
  • Adjustable monitor mounted on a flexible arm that allows for optimal image viewing with landscape or portrait mode
  • Easy integration into a crowded operating room due to its minimal system footprint

With the acquisition of BK Medical in 2021, GE HealthCare adds the fast-growing field of real-time surgical visualization to its pre- and post-operative ultrasound capabilities, creating an end-to-end offering through the full continuum of care. GE HealthCare has a long history of ultrasound innovation and a successful track record of growing technology acquisitions.

For more information on the bkActiv system for Urology visit: https://www.bkmedical.com/systems/bkactiv-urology/

For more information on the bkActiv system for Colorectal Surgery visit: https://www.bkmedical.com/systems/bkactiv-colorectal-surgery/

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy